Publicación:
Pneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru.

dc.contributor.authorGonzales Jaimes, Brayan Enrique
dc.contributor.authorMercado Zarate, Erik Hernan
dc.contributor.authorCastillo Tokumori, Franco
dc.contributor.authorMontero Quiñe, Andrea Estefania
dc.contributor.authorLuna Muschi, Alessandra Joanna
dc.contributor.authorMarcelo Ragas, Madhelli Natividad
dc.contributor.authorCampos, Francisco
dc.contributor.authorChaparro Dammert, Luis Eduardo
dc.contributor.authorDel Águila, Olguita
dc.contributor.authorCastillo Díaz, María Esther
dc.contributor.authorSaenz, Andrés
dc.contributor.authorReyes, Isabel
dc.contributor.authorHernandez, Roger
dc.contributor.authorOchoa Woodell, Theresa Jean
dc.coverage.spatialLima, Perú
dc.date.accessioned2026-04-28T22:47:07Z
dc.date.issued2023
dc.description.abstractOBJECTIVE: To determinate the frequency of Streptococcus pneumoniae nasopharyngeal carriers, serotypes and antimicrobial resistance in healthy children in Lima, Peru, post-PCV13 introduction and to compare the results with a similar study conducted between 2006 and 2008 before PCV7 introduction (pre-PCV7). METHODS: A cross-sectional multicenter study was conducted between January 2018 and August 2019 in 1000 healthy children under two years of age. We use standard microbiological methods to determinate S. pneumoniae from nasopharyngeal swab, Kirby Bauer and minimum inhibitory concentration methods to determinate antimicrobial susceptibility and whole genomic sequencing to determinate pneumococcal serotypes. RESULTS: The pneumococcal carriage rate was 20.8 % vs. 31.1 % in pre-PCV7 (p < 0.001). The most frequent serotypes were 15C, 19A and 6C (12.4 %, 10.9 % and 10.9 % respectively). The carriage of PCV13 serotypes after PCV13 introduction decreased from 59.1 % (before PCV7 introduction) to 18.7 % (p < 0.001). Penicillin resistance was 75.5 %, TMP/SMX 75.5 % and azithromycin 50.0 %, using disk diffusion. Penicillin resistance rates using MIC breakpoint for meningitis (MIC ≥ 0.12) increased from 60.4 % to 74.5 % (p = 0.001). CONCLUSION: The introduction of PCV13 in the immunization program in Peru has decreased the pneumococcal nasopharyngeal carriage and the frequency of PCV13 serotypes; however, there has been an increase in non-PCV13 serotypes and antimicrobial resistance.en_US
dc.identifier.doihttps://doi.org/10.1016/j.vaccine.2023.05.042
dc.identifier.scopus2-s2.0-85162094552
dc.identifier.urihttps://hdl.handle.net/20.500.12866/19114
dc.language.isoeng
dc.publisherElsevier
dc.relation.ispartofurn:issn:1873-2518
dc.relation.ispartofseriesVaccine (Amsterdam)
dc.relation.issn1873-2518
dc.rightshttp://purl.org/coar/access_right/c_14cb
dc.subjectStreptococcus pneumoniaeen_US
dc.subjectNasopharyngeal carriersen_US
dc.subjectPneumococcal conjugate vaccineen_US
dc.subjectSerotypesen_US
dc.subjectAntimicrobial resistanceen_US
dc.subject.meshStreptococcus pneumoniae
dc.subject.meshEnfermedades Nasofaríngeas
dc.subject.meshVacuna Neumocócica Conjugada Heptavalente
dc.subject.meshSerogrupo
dc.subject.meshFarmacorresistencia Microbiana
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#1.06.03
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.08
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.03.05
dc.titlePneumococcal serotypes and antibiotic resistance in healthy carriage children after introduction of PCV13 in Lima, Peru.en_US
dc.typeinfo:eu-repo/semantics/article
dc.type.localArtículo de revista
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Archivos